View of Clinical, organizational, and pharmacoeconomic perspectives of dalbavancin vs standard of care in the infectious disease network

Return to Article Details Clinical, organizational, and pharmacoeconomic perspectives of dalbavancin vs standard of care in the infectious disease network Download Download PDF